Clinical trial
Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung…
NCT00453115 · National Cancer Center, Korea, Other · Unknown status
Key facts
| NCT number | NCT00453115 |
|---|---|
| Title | Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC) |
| Official title | A Phase II Study of Gemcitabine Plus Oxaliplatin for Patients With Advanced Stage IIIB or IV Non-Small Cell Lung Cancer |
| Lead sponsor | National Cancer Center, Korea, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | Oxaliplatin, Gemcitabine |
| Enrollment | 43 |
| Start date | Jan 1, 2006 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2011 |
| First posted | Mar 28, 2007 |
| Last update posted | Oct 25, 2010 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: